Skip to content

A practical randomized dose control study on the treatment of Hashimoto's thyroiditis subclinical hypothyroidism (liver stagnation and spleen deficiency syndrome) with Shusgan Huazhuo Ni Jia Fang

A practical randomized dose control study on the treatment of Hashimoto's thyroiditis subclinical hypothyroidism (liver stagnation and spleen deficiency syndrome) withShusgan Huazhuo Ni Jia Fang

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000603
Enrollment
Unknown
Registered
2024-10-23
Start date
2024-10-30
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto's thyroiditis

Interventions

control group:Shusgan Huazhuo Ni Jia Fang
Experimental Group:Shusgan Huazhuo Ni Jia Fang

Sponsors

Xiyuan Hospital China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) The diagnosis of western medicine was in accordance with mild subclinical hypothyroidism stage of HT and the diagnosis of TCM was in accordance with liver stagnation and spleen deficiency syndrome. (2) not treated with thyroxine before study entry; (3) age of 18-70 years old both sexes; (4) Able to provide detailed contact information no short-term relocation able to cooperate with the follow-up; (5) those who voluntarily participated in the clinical observation and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) HT patients with thyroid malignant tumors; (2) combined with diseases affecting thyroid function such as hypothalamus pituitary gland adrenal gland or other serious diseases of other organs or systems such as other malignant tumors or serious heart liver or kidney diseases; (3) subclinical hypothyroidism secondary to thyroidectomy and radioiodine therapy; "Convalescent patients with low T3 syndrome central hypothyroidism renal insufficiency or glucocorticoid deficiency;" Drug-induced subclinical hypothyroidism; (4) Patients with allergic constitution or allergic to multiple drugs and food or known to be allergic to the test drug (including its ingredients). (5) those with serious mental and psychological abnormalities; (6) those who plan to be pregnant or are pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
TCM symptom rating table;Clinical hypothyroidism conversion rate and clinical hypothyroidism conversion time (within 1 year);Thyroid imaging;T3T4TSH;TPOATgAb;Quality of life rating sheet;

Countries

China

Contacts

Public ContactGaorui

China College of Traditional Chinese Medicine Xiyuan Hospital

ruigao@163.com13911097756

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026